Posted by Michael Wonder on 14 Apr 2021
Europe bets heavily on Pfizer in vaccine strategy overhaul
15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca and Johnson & Johnson, in a new strategy that pivots heavily towards Pfizer and its new mRNA technology.
In a surprise statement on Wednesday, European Commission President Ursula von der Leyen said negotiations were under way to buy 1.8 billion Pfizer-BioNTech doses for 2022 and 2023 – enough to fully vaccinate every person in the bloc once a year for the next two years.
